Applied Clinical Trials-06-01-2021

Centralized medical imaging providers must challenge their current processes to improve patient diversity.

Survey data shows individuals are not informed on how COVID-19 could affect their conditions.

COVID-19 forces life sciences industry to make long overdue changes.

How COVID-19 blazed a new trail for greater patient inclusion.

Affirming and advancing patient engagement and digital transformation.

Charles Sydnor, CCRA, ACRP-CP, project manager at Crofoot, discusses how offering a digital patient experience in trials enables the site to provide better patient care.

A brief look at the market for mergers and acquisitions since the year of COVID.

Chairman and Founder of MJH Life Sciences, Mike Hennessy Sr. explores the main discussion points covered in the June issue of ACT.

Click the title above for a link to open the Applied Clinical Trials June 2021 issue in an interactive PDF format.

Conclusions from the Global Health Summit provide plenty of support for research, innovation, investment, and incentivization.

FDA has responded to pressures for quick and reliable processes with multiple guidance documents and policy initiatives for updating the clinical research process.

Building authentic trust lays at the heart of creating more patient-centric trials.